UHRF1 |
Multiple |
HCC |
Senescence escape, genomic instability |
Cui et al. (2014) [117], Mudbhary et al. (2014) [5] |
DNMT1 |
Multiple |
No |
Unknown |
Li et al. (2010) [118], Chen et al. (2006) [119], Xu et al. (2010) [120] |
DNMT3a/b |
AML, melanoma |
No |
Unknown |
Im et al. (2014) [121], Nguyen et al. (2002) [109] |
TET2 |
Leukemia |
Myelodysplasia |
Unknown |
Gjini et al. (2015) [8], Scourzic et al. (2015) [122] |
EZH2 |
Prostate, HCC, myeloma |
No |
Unknown |
Chinaranagari et at. (2014) [110], Hung et al. (2014) [123] |
SETDB1 |
Melanoma |
Melanoma |
Cooperation with BRAFV 600E
|
Ceol et al. (2011) [7] |
SUV39H1 |
HCC, gastric colorectal, breast |
Rhabdo- myosarcoma |
Cyclin B1 repression |
Albacker et al. (2013) [9], Cai et al. (2014) [124], Chiba et al. (2013) [92], Khanal et al. (2013) [125] |
G9a |
Squamous cell carcinoma, glioma |
No |
Unknown |
Tao et al. (2014) [126], Zhong et al. (2015) [127] |